Shanghai Shen Lian Biomedical Corp (688098) — Cash Flow-to-Debt Ratio
Shanghai Shen Lian Biomedical Corp (688098) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥21.52 Million could theoretically repay 0% of its total liabilities (CN¥139.42 Million) in one year. See 688098 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shen Lian Biomedical Corp Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Shanghai Shen Lian Biomedical Corp across 13 annual periods. Also explore 688098 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Shen Lian Biomedical Corp (2013–2025)
Year-by-year debt coverage analysis for Shanghai Shen Lian Biomedical Corp. For market capitalisation and broader financial context, see 688098 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥33.08 Million | CN¥143.41 Million | ▼ -66.8% |
| 2024 | 0.70x | CN¥89.36 Million | CN¥128.50 Million | ▲ +1614.7% |
| 2023 | 0.04x | CN¥3.53 Million | CN¥86.93 Million | ▼ -51.7% |
| 2022 | 0.08x | CN¥9.09 Million | CN¥108.21 Million | ▼ -88.3% |
| 2021 | 0.72x | CN¥90.12 Million | CN¥125.48 Million | ▼ -24.0% |
| 2020 | 0.95x | CN¥111.73 Million | CN¥118.20 Million | ▲ +192.2% |
| 2019 | 0.32x | CN¥53.81 Million | CN¥166.33 Million | ▼ -51.6% |
| 2018 | 0.67x | CN¥121.13 Million | CN¥181.18 Million | ▲ +28.1% |
| 2017 | 0.52x | CN¥74.61 Million | CN¥142.92 Million | ▲ +54.8% |
| 2016 | 0.34x | CN¥48.00 Million | CN¥142.32 Million | ▲ +88.9% |
| 2015 | 0.18x | CN¥30.86 Million | CN¥172.90 Million | ▼ -51.6% |
| 2014 | 0.37x | CN¥105.98 Million | CN¥287.32 Million | ▲ +45.3% |
| 2013 | 0.25x | CN¥51.79 Million | CN¥203.94 Million | — |